IHH Healthcare Retains Fortis Open Offer Price, Adds Interest for Eligible Shareholders
Malaysia’s IHH Healthcare has maintained the open offer price for Fortis Healthcare at ₹170 per share for a 26% stake,…
Economics
Read Global and Indian Healthcare Economics and Market news with TISHHA. Fastest coverage of all aspects related to industry deals, policies, plans, mergers and much more
Read More
Centre Slashes GST on Medical Equipment to 5% to boost Healthcare Affordability
In a major reform the Finance Ministry has announced a sharp reduction in Goods and Services Tax (GST) on medical…
India Mulls Lowering Tariffs for US Medical Devices
To mitigate the potential impact of the US tariff threat on Indian exports, the Indian government may decide to offer…
Union Budget 2025-26: Healthcare Boosted, But Challenges Ahead
Sugandh Khandelwal The Union Budget 2025-26 presents several positives for the healthcare sector at first glance, but a deeper analysis…
A Health-First Budget: Investing in India’s Well-Being
This year’s budget prioritizes healthcare advancements in India, introducing initiatives such as 200 day-care chemotherapy centers, expanding medical seats, and…
Health Insurers Deny Claims Worth ₹15,100 Crore in FY24
India’s health insurers disallowed claims totaling ₹15,100 crore during the financial year 2023-24, accounting for 12.9% of all claims filed,…
Consolidation Surge: Key Healthcare Mergers and Acquisitions in 2024
Credit:- Sugandh Khandelwal 2024 has been a transformational year for the healthcare sector in India, with mergers and acquisitions (M&A)…
Reliance Acquires Karkinos Healthcare in ₹375 Crore All-Cash Deal
Reliance Industries Ltd (RIL), led by billionaire Mukesh Ambani, traded flat in early deals on Monday despite announcing the acquisition…
India’s healthcare sector is projected to reach US$ 320 billion (Rs. 27,28,320 crore) by 2028, according to a recent report
India’s healthcare sector is projected to reach US$ 320 billion (Rs. 27,28,320 crore) by 2028, according to a recent report…
Mankind Pharma and Innovent Collaborate to Improve Cancer Care Access in India
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….